ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$1.09
+0.05 (+4.81%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,889.0% upside
Low Target $17.80
Average Target $32.58
High Target $40.39
Current Price $1.09
Current
$1.09
Target
$32.58
$17.80 $32.58 avg $40.39
Scenario Analysis
Bear Case
$17.80
1,533.0%
Low target
Base Case
$32.58
+2,889.0%
Avg target
Bull Case
$40.39
+3,605.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.35
-53.6% from high
52-Week Low
$0.61
+77.6% from low
Target vs 52W High
$32.58
+1,286.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%